IN2013MU03641A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03641A
IN2013MU03641A IN3641MU2013A IN2013MU03641A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A IN 3641MU2013 A IN3641MU2013 A IN 3641MU2013A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A
Authority
IN
India
Prior art keywords
amorphous form
idelalisib
relates
abstract
processes
Prior art date
Application number
Other languages
English (en)
Inventor
Shriprakash Dhar Dwivedi
Brij Khera
Kumar Kamlesh Singh
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to PCT/IN2014/000724 priority Critical patent/WO2015092810A2/fr
Priority to IN3641MU2013 priority patent/IN2013MU03641A/en
Publication of IN2013MU03641A publication Critical patent/IN2013MU03641A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3641MU2013 2013-11-20 2014-11-19 IN2013MU03641A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000724 WO2015092810A2 (fr) 2013-11-20 2014-11-19 Forme amorphe d'idélalisib
IN3641MU2013 IN2013MU03641A (fr) 2013-11-20 2014-11-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3641MU2013 IN2013MU03641A (fr) 2013-11-20 2014-11-19

Publications (1)

Publication Number Publication Date
IN2013MU03641A true IN2013MU03641A (fr) 2015-07-31

Family

ID=52785145

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3641MU2013 IN2013MU03641A (fr) 2013-11-20 2014-11-19

Country Status (2)

Country Link
IN (1) IN2013MU03641A (fr)
WO (1) WO2015092810A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016097314A1 (fr) * 2014-12-19 2016-06-23 Sandoz Ag Formes amorphes et cristallines d'idélalisib et procédé pour les produire
WO2016147206A1 (fr) 2015-03-13 2016-09-22 Mylan Laboratories Limited Procédé pour la préparation d'idélalisib amorphe et son mélange préliminaire
WO2016157136A1 (fr) 2015-04-02 2016-10-06 Mylan Laboratories Ltd Formes cristallines de l'idélalisib
CN108033961A (zh) * 2015-04-15 2018-05-15 上海方楠生物科技有限公司 一种艾德力布的无定型物及其制备方法
WO2017137097A1 (fr) * 2016-02-12 2017-08-17 Synthon B.V. Composition pharmaceutique comprenant de l'idelalisib sous forme amorphe
WO2017175184A1 (fr) * 2016-04-07 2017-10-12 Laurus Labs Limited Procédé de préparation de la forme amorphe d'idélalisib
EP3272348A1 (fr) 2016-07-21 2018-01-24 LEK Pharmaceuticals d.d. Composition pharmaceutique comportant de l'idelalisib
WO2019178596A1 (fr) 2018-03-16 2019-09-19 Johnson Matthey Public Limited Company Formes à l'état solide solvatées de pyridine ou de n,n-diméthylacétamide d'idélalisib solvaté, leur utilisation et leur préparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2605792T3 (es) 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona

Also Published As

Publication number Publication date
WO2015092810A3 (fr) 2015-08-13
WO2015092810A2 (fr) 2015-06-25

Similar Documents

Publication Publication Date Title
PH12015501710A1 (en) Combination formulation of two antiviral compounds
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
IN2015DN00127A (fr)
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
IN2013MU03641A (fr)
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
IN2013MU00848A (fr)
IL243435B (en) Pharmaceutical preparations of pancreatin with high potency
IN2013MU00646A (fr)
IN2013MU03918A (fr)
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
SG10201900598TA (en) Factor viii formulation
IN2014CH00840A (fr)
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
EP3063152A4 (fr) Préparation pratique de morphinan-6-ols n-substitués à partir de morphinan-6-ones
MX2015016603A (es) Composiciones de corticosteroides.
IN2013MU01113A (fr)
NZ721832A (en) Solid forms of tenofovir
IN2013MU03317A (fr)
IN2013MU02528A (fr)
IN2013MU03768A (fr)
IN2013CH05770A (fr)